Eppdata (@eppdata_) 's Twitter Profile
Eppdata

@eppdata_

Eppdata is uniquely positioned to support the lifecycle of clinical studies with information technology development and domain specific medical expertise.

ID: 1881717252707262464

linkhttp://eppdata.de calendar_today21-01-2025 14:57:31

4 Tweet

8 Takipçi

1 Takip Edilen

Eppdata (@eppdata_) 's Twitter Profile Photo

Eppdata provided core lab services for the TENSION trial, proving that patients with large infarcts benefit from endovascular thrombectomy. Check out recent The Lancet publication: lnkd.in/gj4SZKYQ 📩 Contact us to collaborate on your next neurovascular trial! #corelab

Eppdata provided core lab services for the TENSION trial, proving that patients with large infarcts benefit from endovascular thrombectomy.

Check out recent The Lancet publication:
lnkd.in/gj4SZKYQ

📩 Contact us to collaborate on your next neurovascular trial!

#corelab
Eppdata (@eppdata_) 's Twitter Profile Photo

Trustworthy data is the cornerstone of any successful clinical trial. At Eppdata we're committed to : Secure Data Handling Standardized Imaging Protocols Unbiased Analysis Ready to elevate your research? 📩 Contact us today! #dataIntegrity #corelab #MedicalResearch

Trustworthy data is the cornerstone of any successful clinical trial.

At Eppdata we're committed to :

Secure Data Handling 
Standardized Imaging Protocols 
Unbiased Analysis 

Ready to elevate your research?

📩 Contact us today!

#dataIntegrity #corelab #MedicalResearch
Eppdata (@eppdata_) 's Twitter Profile Photo

MMA embolization reduces treatment failures in chronic subdural hematoma by over 50%. Eppdata provided core lab services for the STEM trial. Read more at the NEJM: bit.ly/3DH8Ak0 Interested in advancing your research? 📩 Contact us today! #MedicalResearch

MMA embolization reduces treatment failures in chronic subdural hematoma by over 50%.  

Eppdata provided core lab services for the STEM trial.   

Read more at the NEJM: bit.ly/3DH8Ak0  

Interested in advancing your research?
📩 Contact us today!

#MedicalResearch
Eppdata (@eppdata_) 's Twitter Profile Photo

ERASER is the first mechanical thrombectomy study with a primary endpoint based on predictive analytics enabling intraindividual virtual comparisons. This innovative study design paves the way for faster, more reliable evaluations in clinical trials. #Stroke #NeuroIntervention

ERASER is the first mechanical thrombectomy study with a primary endpoint based on predictive analytics enabling intraindividual virtual comparisons.

This innovative study design paves the way for faster, more reliable evaluations in clinical trials.

#Stroke #NeuroIntervention
Eppdata (@eppdata_) 's Twitter Profile Photo

Congratulations: Great engineering and impressive results. TICI double read with full end-to-end traceability. Proud to be part of your journey! Jens Fiehler Raul G Nogueira, MD, FAHA, FSVIN